OrganiGram (OGI) Q3 2025 Earnings Call August 13, 2025 08:00 AM ET Speaker0Good morning. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Organigram Global Third Quarter Fiscal twenty twenty five Earnings Conference Call. After the speakers' remarks, there will be a question and answer session. We ask that you please limit yourself to one question and one follow-up question.You may re queue if you have any further questions. Thank you. Ma ...

Industry Overview - The legal cannabis industry in the USA has faced a continuous downtrend, with many marijuana stocks falling significantly, leading to challenges in profit-taking for investors [1] - Shareholders are adopting a long-term strategy, hoping for federal legalization and banking reforms to enhance the safety of their investments [2] - Speculation around better reforms and opportunities in international markets like Canada and Europe is driving interest in the cannabis sector [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. Recently partnered with Redemption Cannabis to launch products in West Virginia [4][5] - **Curaleaf Holdings, Inc.**: Engaged in the production and distribution of cannabis products both domestically and internationally. Scheduled to report Q2 2025 financial earnings on August 6, 2025 [5][8] - **Cresco Labs Inc.**: Cultivates and sells retail and medical cannabis products. Recently changed its auditor from Marcum LLP to Baker Tilly US, LLP, with shareholder ratification planned for the next annual meeting [9] Stocks to Watch - Top marijuana stocks identified for potential investment include Trulieve Cannabis Corp., Curaleaf Holdings, Inc., and Cresco Labs Inc. [6]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time and has consistently ranked highly in securities class action settlements [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]